Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Traws Pharma, Inc. | Chief Science Officer Virology | Stock Option (right to purchase) | 32.4K | Oct 12, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRAW | Traws Pharma, Inc. | Oct 12, 2025 | 1 | $0 | 4 | Oct 15, 2025 | Chief Science Officer Virology |
TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 3 | $0 | 4 | Apr 3, 2024 | Chief Science Officer Virology |
TRAW | Onconova Therapeutics, Inc. | Apr 1, 2024 | 0 | $0 | 3 | Apr 3, 2024 | Chief Science Officer Virology |